Dyne Submits DMD Treatment Application
Dyne submits biologics license application for Duchenne muscular dystrophy treatment, seeking regulatory approval. This could impact the biotech sector.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.